Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation

Published:2017-02 Issue:2 Volume:24 Page:89-94
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Egawa Hiroto¹,Umeshita Koji²,Uemoto Shinji³

Affiliation:

1. Department of Surgery; Institute of Gastroenterology; Tokyo Women's Medical University; 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666 Japan

2. Department of Surgery; Osaka University; Osaka Japan

3. Department of Surgery; Kyoto University; Kyoto Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Reference10 articles.

1. Present status of ABO-incompatible living donor liver transplantation in Japan;Egawa;Hepatology,2008

2. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation;Egawa;Transplantation,2004

3. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study;Egawa;Am J Transplant,2014

4. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation;Haga;Liver Transpl,2004

5. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation;Colombat;Blood,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary complications after ABO-incompatible liver transplantation;European Radiology;2024-07-09

2. Chronological alterations in de novo malignancies after living‐donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios;Journal of Hepato-Biliary-Pancreatic Sciences;2024-06-06

3. Liver transplantation: the recipient;Living Donor Organ Transplantation;2024

4. Challenge for difficult-to-treat hepato-biliary-pancreatic cancer;Tenri Medical Bulletin;2023-12-25

5. Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus;World Journal of Gastroenterology;2023-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3